Close
ACHEMA MIDDLE EAST 2026
LogiPharma 2026

Drug Development

      GSK joins forces with the University of California to advance genomic research and improve drug discovery

      Manufacturing
      GlaxoSmithKline plc announced a five-year collaboration with the University of California to establish a state-of-the-art laboratory for CRISPR technologies, the Laboratory for Genomics Research...

      Savara Announces Results of IMPALA a Phase 3 Study of Molgradex for the Treatment of Autoimmune Alveolar Pulmonary Proteinosis (aPAP)

      Manufacturing
      Savara Inc. , an orphan lung disease company announced top line data from IMPALA, a pivotal Phase 3 clinical study evaluating Molgradex, an inhaled...

      Hamilton And Enable Biosciences Team Up to Automate Ultra-Sensitive Antibody Detection Assay Platform

      Drug Development
      Hamilton Company and Enable Biosciences are pleased to announce their collaboration to provide fully automated processing of up to 96 liquid biopsy samples at...

      FDA approves Celgenes R2 for two types of indolent lymphoma

      FDA Approvals
      Celgene has announced that the US FDA has approved Revlimid (lenalidomide) in combination with rituximab (R2) for patients with previously treated follicular lymphoma (FL)...

      ICON Awarded Clinical Research Team of the Year and Best in Health Economics and Outcomes Research

      Clinical Trials
      ICON plc, a global provider of drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device industries, today announced that it has...

      FDA and Infant Bacterial Therapeutics agree on the design of Phase III study

      FDA Approvals
      For an extended time, IBT has consulted with the US FDA on how the company’s planned Phase III study should be designed. IBT announced the...

      Allergan Expands PLEDGE Clinical Research Program in Diabetic Gastroparesis

      Drug Development
      Allergan plc announced the expansion of the PLEDGE program with a fifth study now evaluating relamorelin, an investigational, ghrelin agonist being studied for the...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

      Resources

      Advertise

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.